论文部分内容阅读
难治性高血压(treatment resistant hypertension,TRH)为即使服用超过3种不同种类的最优剂量降压药,患者的血压仍未能控制,诊室内外测量血压≥140/90mm Hg(1mm Hg=0.133kPa)。TRH比较常见预后也差。醛固酮拮抗剂(aldosterone antagonist,AA)和肾素指导疗法(renin-guided therapy,RGT)均是可以改善TRH患者血压控制的有效治疗策略,但
Treatment resistant hypertension (TRH) is a patient whose blood pressure is uncontrollable even with the optimal dose of more than 3 different types of antihypertensive drugs. Blood pressure measured inside and outside the clinic is ≥140 / 90 mm Hg (1 mm Hg = 0.133 kPa). TRH more common prognosis is poor. Aldosterone antagonist (AA) and renin-guided therapy (RGT) are both effective strategies to improve BP control in patients with TRH